Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 358,399 | 380,330 | 427,222 | 161,412 | 178,941 |
| Marketable Securities | 454,796 | 529,159 | 482,578 | 483,531 | 476,072 |
| Receivables | 309 | 2,510 | 3,995 | 4,673 | 4,940 |
| TOTAL | $824,467 | $922,092 | $922,753 | $660,185 | $675,108 |
| Non-Current Assets | |||||
| PPE Net | 20,286 | 19,718 | 18,536 | 18,659 | 18,267 |
| Intangibles | 72,614 | 72,881 | 73,148 | 73,415 | 73,683 |
| Other Non-Current Assets | 66,865 | 59,018 | 58,811 | 59,671 | 58,852 |
| TOTAL | $159,765 | $151,617 | $150,495 | $151,745 | $150,802 |
| Total Assets | $984,232 | $1,073,709 | $1,073,248 | $811,930 | $825,910 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 29,627 | 29,784 | 19,912 | 21,306 | 24,382 |
| Accrued Expenses | 50,159 | 42,557 | 27,368 | 29,446 | 32,186 |
| TOTAL | $85,541 | $78,059 | $54,635 | $61,984 | $73,271 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 1,434 | 4,459 | 9,686 |
| Other Non-Current Liabilities | 58,075 | 57,790 | 59,370 | 57,733 | 58,654 |
| TOTAL | $61,233 | $64,815 | $66,395 | $64,758 | $71,220 |
| Total Liabilities | $146,774 | $142,874 | $121,030 | $126,742 | $144,491 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 109,565 | 109,170 | 106,313 | 90,492 | 88,791 |
| Common Shares | 11 | 11 | 11 | 9 | 9 |
| Retained earnings | -976,171 | -867,737 | -769,439 | -701,341 | -644,834 |
| Other shareholders' equity | -871 | -1,251 | -556 | -1,780 | -2,419 |
| TOTAL | $837,458 | $930,835 | $952,218 | $685,188 | $681,419 |
| Total Liabilities And Equity | $984,232 | $1,073,709 | $1,073,248 | $811,930 | $825,910 |